Clarus IV-A, L.P.

Clarus IV-A, L.P. is a declared insider of Galera Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 8 filings, all for trades on 12 November 2019.

The open-market record is one-sided, with 4 purchases worth €2.7M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The median purchase comes to €726k. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 14 November 2019, the filings show a transaction in Galera Therapeutics, Inc. The most recent open-market purchase was published on 14 November 2019, 2,552 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.